42231 Investors following Ranbaxy Labs. Share this News with them.
0
Like this story, share it with millions of investors on M3
Ranbaxy Q4 net seen down 10% at Rs 165 cr
Ranbaxy will declare its Q4 results. According to CNBCTV18 estimates, its Q4 net profit is seen down 10% at Rs 165 crore versus Rs 183.3 crore in the corresponding quarter previous year.
Ranbaxy will declare its Q4 results. According to CNBCTV18 estimates, its Q4 net profit is seen down 10% at Rs 165 crore versus Rs 183.3 crore in the corresponding quarter previous year.
Its net sales are seen up 2% at Rs 1811 crore versus Rs 1776.90 crore.
RANBAXY POLL Q4 CY08 YoY -Net sales up 2% at Rs 1811 Cr vs Rs 1776.90 Cr - Operating profit at Rs 283.78 Cr vs Rs 266.5 Cr -OPM at 15.7 % vs 15 % - Net profit down 10% at Rs 165 Cr vs Rs 183.3Cr # CNBC TV 18 Estimates
RANBAXY POLL Full Year CY04 -Net sales up 12% at Rs 6851.74 Cr vs Rs 6134 Cr - Operating profit at Rs 984.28 Cr vs Rs 1330.30 Cr -OPM at 14.37 % vs 21.69 % - Net profit up 45% at Rs 745.85 Cr vs Rs 515.10 Cr #CNBC TV18 Estimates
RANBAXY Factors to watch for -Revenues to expand just about 2% due to higher base of Q4CY07 and absence of big exclusivity in US -Currency appreciation to impact -Expect improvement in EBIDTA margins due to higher growth in semi-regulated markets ( including Romania) -Higher Depreciation and interest cost will result in PAT de-growth -Drop in profit is also because of lower forex gains during the quarter as compared to Q4CY07